Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life

作者：Amir Ardeshir, Daniel O’Hagan, Isha Mehta, Siddhartha Shandilya, Lincoln Hopkins, Lourdes Adamson, Marcelo J. Kuroda, P. Hahn, Lucas A. B. da Costa, Sebastian Fuchs, José M. Martinez-Navío, Matthew R. Gardner, Koen K. A. Van Rompay, Diogo M. Magnani, Jeffrey D. Lifson, Guangping Gao, Michael Farzan, Ronald C. Desrosiers, Jishnu Das, Maurício A. Martins · 发表于：Nature · 年份：2025 · DOI：10.1038/s41586-025-09330-2 · 被引用次数：16 · 研究领域：HIV Research and Treatment、HIV/AIDS drug development and treatment、Cytomegalovirus and herpesvirus research

Despite advances in HIV-1 prophylaxis, vertical transmission remains a pressing problem in developing countries1. Given the promise of broadly neutralizing antibodies (bNAbs) for HIV-1 prevention2, we hypothesized that neonatal delivery of bNAbs using adeno-associated virus (AAV) could provide durable HIV-1 immunity during infancy. Here, using infant rhesus macaques (Macaca mulatta) as a model, we show that a one-time administration of an AAV vector encoding bNAb 3BNC117 at birth led to sustained bNAb expression for more than three years without redosing. This approach significantly protected both infant and pre-adolescent rhesus macaques from infection with simian–human immunodeficiency virus in mucosal challenge models that mimic HIV-1 transmission through breastfeeding and sexual intercourse. Age at the time of AAV-3BNC117 administration was a main determinant of success and was inversely correlated with the incidence of host anti-drug antibodies that restricted bNAb expression. Consistent with principles of neonatal tolerance3,4, newborn rhesus macaques exhibited higher levels of bNAb expression than older infants and juveniles following AAV-3BNC117 dosing. Furthermore, in utero exposure to recombinant 3BNC117 suppressed anti-drug antibodies and improved AAV-vectored delivery of this bNAb in older infants. Thus, our results suggest that neonatal and fetal immunological tolerance can be leveraged to improve postnatal AAV delivery of HIV-1 bNAbs in primates. Since years-lon...